Off a Scripps website, 2004--a big
fwiw here, but I have highlighted a
few companies for the hell of it.
Under the headline of "Too Many Damn Companies".
I don't know which company dpii should merge with,
but they ought to do something, unless they like
to trade at 1x cash...
On the one hand, I admire frugalitas--on the other,
I'd like to get a trade out of DPII shares someday...
It would suck a little if I lose hope before a
liquidity event, as I did with glgc. While it certainly
is a gift to buy for free, this has been a rather
quiet period without news or publications of any kind.
----------------------
The following corporations arrange interviews on TSRI's campus with graduate students for recruitment purposes.
3-Dimensional
Abbott Laboratories
ActivX Biosciences
Albany Molecular
Amgen
Anadys Pharmaceuticals
ArQule
Array BioPharma
Aventis Pharmaceuticals
Bayer Research Center
Bend Research
Beyond Genomics
Boehringer-Ingelheim
Bristol Myers Squibb
Celera
CelGene
ChemBridge Research Laboratories LLC
ChemoCentryx
ChemRx this is in DPII, as is IRORI--mm
Chiron Corporation
Diversa
Eisai Research Institute
Eli Lilly
Exelixis, Inc.
Genentech
Gilead Sciences
GlaxoSmithKline
Infinity Pharmaceuticals, Inc.
Johnson & Johnson
Kalypsys
Lexicon Pharmaceuticals
Locus Discovery
Materia
Merck & Co., Inc.
Metabasis Therapeutics
Millennium Pharmacueticals, Inc.
New Biotics
Pfizer
Pharmacia
Roche Bioscience
Schering-Plough
Signature Bioscience, Inc.
Sunesis Pharmaceuticals, Inc.
Syrrx, Inc.
Theravance, Inc.
Tularik
Versicor, Inc.
Wyeth Research
Xenoport, Inc. |
